Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Torben Noerup Nielsen who wrote (15816)	2/24/1998 10:11:00 PM
From: Henry Niman	Read Replies (1) of 32384

Torben, When I saw GLYC and CYTL in the heading, I thought that LGND was licensing out the GLYC technology. However, I now think that the announcement had more to do with patent enforcement than technology licensing. I think that GLYC had some rather broad patents and CYTL was infringing. To settle, they worked out a milestone/royalty agreement that involved use of the GLYC patents. The agreement is non-exclusive. Thus LGND can go after other infringers and/or they can still licence out the technology to third parties.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next